Partner Content Partner Content Unlocking the Potential of Targeting the Innate Immune Syste... Ready to Catalyze the Next Wave of Inflammasome Therapies?
R&D Supercharging clinical development with RWE – with Recursion... Greater availability of real-world data and real-world evidence is rapidly changing the landscape of drug development.
News FDA plans to phase out animal testing for antibodies The FDA has said it intends to reduce or replace animal testing of some medicines, including monoclonal antibodies, with other methods.
R&D Defining success for early-stage, small biotech trials Small biotech companies encounter significant challenges in designing and implementing clinical development programmes.
R&D Partner Content 6th Cytokine-Based Drug Development Summit 2025 With more cytokine-based drugs entering clinical trials and novel combination and masking technologies being used, there is a growing need for experts to discuss, understand, and build on t
Digital Balancing innovation and efficiency in clinical trials: Is t... Clinical trials face rising complexity, but simplifying processes and focusing on user experiences can enhance efficiency and patient outcomes
News Third death reported with a Sarepta gene therapy A third fatality has been recorded among patients receiving treatment with a Sarepta gene therapy, adding to the troubles being faced by the company.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
